Arbutus Biopharma

ABUS

5.07

-0.13

-2.5%

Please Login or Register

Login|Register FREE

Stock Price
Open: 5.05
Prev. Close: 5.20
Low/Hi: 5.00 - 5.40
52-Week: 2.35 - 8.25
Volumes
Equity: 76,973
90-Day Avg: 366,024
Option:
90-Day Avg: 148
Volatility
Todays Stock Vol: 77.7
20-Day (HV): 70.6
52-Week (HV): 65.9
30-Day IV: 52.3 +2.6
IV Pct Rank: 17% Subdued
Fundamental
Div. Yield:
Earnings: 14-Mar (Est.)
P/E Ratio:
Market Cap: 288.9 M
Short Int Pct: 0.0%
Pct Held By Inst.: 98.4%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

ABUS Company Events

Upcoming Events
Event Event Date Location Info
No Upcoming Events
Past Events
Event Event Date Location Info
HepDART 2017 Dec 3, 2017 - Dec 7, 2017
American Association for the Study of Liver Diseases (AASLD) Oct 20, 2017 - Oct 24, 2017
Jefferies Gene Technology Summit Oct 12, 2017
Chardan Inaugural Gene Therapy Conference Oct 10, 2017
Discovery on Target: Emerging Oligonucleotide Therapeutics Sep 27, 2017 - Sep 28, 2017
2017 Cantor Fitzgerald Global Healthcare Conference Sep 27, 2017
Discovery on Target: Targeting HBV Sep 25, 2017
Live Webinar on Developments of LNP Delivery for mRNA-based Therapeutics Sep 12, 1:00 PM
2017 Wedbush PacGrow Healthcare Conference Aug 16, 10:55 AM
JMP Securities Life Sciences Conference Jun 20, 2017 - Jun 21, 2017
Jefferies 2017 Global Healthcare Conference Jun 6, 2017 - Jun 9, 2017
Barclays Global Healthcare Conference Mar 14, 2017 - Mar 16, 2017
Cowen 37th Annual Health Care Conference Mar 6, 2017 - Mar 8, 2017
RBC Capital Markets 2017 Global Healthcare Conference Feb 22, 2017 - Feb 23, 2017
RBC Capital Markets 2017 Global Healthcare Conference Feb 22, 2017 - Feb 23, 2017
LEERINK Partners 6th Annual Global Healthcare Conference Feb 15, 2017 - Feb 16, 2017 New York
RBC Capital Markets 2017 Global Healthcare Conference Feb 15, 2017
LEERINK Partners 6th Annual Global Healthcare Conference Feb 15, 2017 - Feb 16, 2017
2017 Disruptive Growth & Healthcare Conference Feb 15, 2017 New York
Liver Diseases (AASLD) Liver Meeting Nov 11, 2016 - Nov 14, 2016
2016 Wedbush PacGrow Healthcare Conference Aug 16, 2016 - Aug 17, 2016
JMP Securities Healthcare Conference Jun 21, 2016 - Jun 22, 2016 New York
Jefferies Healthcare Conference Jun 9, 3:30 PM
Jefferies 2016 Healthcare Conference Jun 7, 2016 - Jun 10, 2016 New York
Arbutus Biopharma Corp Annual Shareholders Meeting May 19, 5:00 PM
Bank of America Merrill Lynch Health Care Conference May 10, 2016
Bank of America Merrill Lynch 2016 Health Care Conference May 10, 2016 - May 12, 2016 Las Vegas
Bloom Burton & Co. Healthcare Investor Conference May 2, 2016 Toronto
29thInternational Conference on Antiviral Research Apr 19, 2016 - Apr 22, 2016 San Diego
i

Dr. Michael Sofia, Arbutus Chief Scientific Officer, on results of several preclinical HBV drug combination studies

EASL 2016 Apr 13, 2016 - Apr 17, 2016 Barcelona, Spain.
i

We are pleased to present data on our core protein/capsid assembly inhibitor program, which supports our strategy of attacking HBV through multiple different mechanisms of action, said Dr. Mark J. Murray, Arbutus President and CEO. Our lead HBV product candidate, ARB-1467, is in an ongoing Phase II study in chronically infected HBV patients. In addition, we are advancing our other HBV programs to support initiation of clinical combination studies in 2017.

Barclays conference Mar 17, 2016
i

Arbutus President and CEO, Dr. Mark J. Murray, will present

Barclays Capital Global Healthcare Conference, Mar 15, 2016 - Mar 17, 2016 Miami
28th Annual ROTH Conference, Mar 13, 2016 - Mar 9, 2016 Orange County
Cowen Health Care Conference Mar 7, 2016
RBC Capital Markets 2016 Global Healthcare Conference Feb 23, 2016 - Feb 24, 2016 New York
LEERINK Partners 5th Annual Global Healthcare Conferecne Feb 11, 2016 New York
i

Arbutus President and CEO, Dr. Mark J. Murray, will present

2015 American Association for the Study of Liver Diseases (AASLD) Liver Meeting Nov 13, 2015 Moscone West Convention Center, San Francisco.
2015 International Meeting on Molecular Biology of Hepatitis B Viruses Oct 4, 2015 Dolce Bad Nauheim, Germany
Baird 2015 Healthcare Conference Sep 10, 2015
i

Mr. Adam Cutler, Arbutus' Senior Vice President, Corporate Affairs, will present

2015 Wedbush PacGrow Healthcare Conference Aug 11, 2015
Jefferies Hepatitis B Summit Aug 6, 2015
i

Dr. Mark J. Murray, Tekmira's President and CEO, will present

JMP Securities Life Sciences Conference Jun 24, 8:00 AM
Deutsche Bank Health Care Conference May 7, 8:20 AM

Wait, Before You Leave...

Want to Know More About ABUS Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon